查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600665

控制释放药物传输市场：依释放机制、技术、应用分类 - 2025-2030 年全球预测

Controlled Release Drug Delivery Market by Release Mechanism, Technology, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年控制释放给药市值为430.7亿美元，预计2024年将达467亿美元，复合年增长率为9.17%，到2030年将达到796.2亿美元。

控制释放药物传递系统是一种复杂的机制，旨在以指定的速率、位置和持续时间将活性药物成分释放到体内，以增强治疗效果。此区域可增强药物功效，同时最大限度地减少副作用，可用于多种药物应用，包括口服、经皮、注射和眼科治疗。随着对精准医疗的日益关注，对此类系统的需求是最大限度地提高临床效益和患者依从性，并且对于慢性病管理、老年护理以及那些需要一致药物水平的疾病来说已经变得至关重要。

主要市场统计
基准年[2023] 430.7亿美元
预测年份 [2024] 467亿美元
预测年份 [2030] 796.2亿美元
复合年增长率（%） 9.17%

该市场的成长是由技术进步、慢性病盛行率上升以及研发投资增加所推动的。生技药品和生物相似药也增加了对先进输送系统的需求。影响成长的关键因素包括奈米技术的整合、聚合物科学的进步以及生物有效性的提高。对于市场相关人员来说，探索生物分解性聚合物、远端药物输送系统和微胶囊技术存在机会。开拓更好的病患教育工具并确保用药依从性也可能为市场渗透开闢新途径。

然而，严格的监管要求、高昂的初始开发成本和复杂的药物释放机制等挑战构成了主要障碍。解决生物相容性问题和管理意外的系统释放错误仍然是重要的挑战。相关人员可以透过专注于先进材料科学、人工智慧驱动的个人化医疗解决方案以及生物製药和医疗保健分析公司之间的合作来利用创新。此外，开发环境永续的方法可以为您带来竞争优势。策略重点在于亚太和拉丁美洲的新兴市场，这些市场的医疗保健服务和基础设施正在迅速改善，也可以带来丰厚的回报。竞争激烈且分散的市场为老牌企业和新兴企业提供了巨大的机会，利用技术进步来满足不断增长的医疗保健需求。

市场动态：揭示快速发展的控制释放给药市场的关键市场洞察

供需的动态交互作用正在改变控制释放给药市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 婴幼儿和老年人对控制释放的需求不断增加
    • 越来越多地采用水凝胶和渗透控制药物传输系统
    • 需要提高治疗效果、降低药物毒性来控制各类疾病
  • 市场限制因素
    • 控制释放药物输送系统的复杂製造工艺
  • 市场机会
    • 奈米技术在控制释放药物传输系统先进药物/药物配方中的发展潜力
    • 控制释放药物传输系统的进展
  • 市场挑战
    • 控制释放製剂的潜在局限性

波特五力：驾驭控制释放给药市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解控制释放给药市场的外部影响

外部宏观环境因素在塑造控制释放给药市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解控制释放给药市场的竞争格局

对控制释放药物输送市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵控制释放市场供应商绩效评估

FPNV定位矩阵是评估控制释放给药市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的广泛资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 婴幼儿和老年人对控制释放的需求不断增加
      • 越来越多地采用水凝胶和渗透控制药物传输系统
      • 需要提高治疗功效并降低药物毒性以控制各种疾病。
    • 抑制因素
      • 控制释放药物输送系统的复杂製造工艺
    • 机会
      • 奈米技术在先进医学/控制释放药物传输系统製剂的潜在发展
      • 控释药物传输系统的进展
    • 任务
      • 控释药物製剂的潜在局限性
  • 市场区隔分析
    • 释放机制：加强研发力度，发展强大的化学活化系统
    • 技术：整合标靶递送以提高治疗指数并减少副作用
    • 应用：注射缓释性给药系统在慢性病管理中日益普及
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章依释放机制分類的控制释放给药市场

  • 活化调变药物输送系统
    • 流体压力激活
    • 磁激活
    • 机械操作的
    • 渗透激活
    • 蒸气压活化
  • 化学活化
    • 酶激活
    • 水解活化
    • pH值活化
  • 回馈控制给药系统
  • 微储库分区控制给药系统
  • 基于聚合物的系统

第七章控制释放给药市场：依技术分类

  • 凝聚
  • 植入
  • 微胶囊化
  • 定向投放
  • 经皮的
  • 阿尔斯特技术

第八章控制释放给药市场：依应用分类

  • 药物释放型支架
  • 点滴帮浦
  • 可注射的
  • 定量吸入器
  • 口服控释给药系统
  • 经皮吸收贴片和眼科贴剂

第九章美洲控制释放给药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太控制释放给药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲控制释放给药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • DelSiTech 宣布完成 1,000 万欧元资金筹措，以推进其基于二氧化硅的药物输送技术平台
    • Chiesi 全球罕见疾病与 Aliada Therapeutics 合作推动跨血脑障壁药物传递平台技术

公司名单

  • Tandem Diabetes Care, Inc.
  • Johnson & Johnson Services, Inc.
  • Insulet Corporation
  • Merck & Co., Inc.
  • Alkermes PLC
  • GlaxoSmithKline PLC
  • Becton, Dickinson and Company
  • Pensatech Pharma GmbH
  • Celares GmbH
  • Trelleborg AB
  • Lonza Group Ltd.
  • Celanese Corporation
  • Boehringer Ingelheim International GmbH
  • CURE Pharmaceutical
  • Baxter International Inc.
  • Medtronic PLC
  • Colorcon, Inc.
  • Adare Pharma Solutions
  • Collegium Pharmaceutical, Inc.
  • Pfizer Inc.
  • Catalent, Inc.
  • Avantor, Inc.
  • Corium, Inc.
  • AMW GmbH
  • Seqens
  • Biogen Inc.
  • Coating Place, Inc.
  • AstraZeneca PLC
Product Code: MRR-A339DAEFA6EE

The Controlled Release Drug Delivery Market was valued at USD 43.07 billion in 2023, expected to reach USD 46.70 billion in 2024, and is projected to grow at a CAGR of 9.17%, to USD 79.62 billion by 2030.

Controlled release drug delivery systems are sophisticated mechanisms engineered to release active pharmaceutical ingredients into the body at predetermined rates, locations, and durations to enhance therapeutic outcomes. This domain enhances drug efficacy while minimizing side effects, making it invaluable across various pharmaceutical applications, including oral, transdermal, injectables, and ocular therapies. With increased focus on precision medicine, the necessity of such systems lies in maximizing clinical benefits and patient compliance, proving essential for chronic disease management, geriatric care, and conditions requiring consistent medication levels.

KEY MARKET STATISTICS
Base Year [2023] USD 43.07 billion
Estimated Year [2024] USD 46.70 billion
Forecast Year [2030] USD 79.62 billion
CAGR (%) 9.17%

The market's growth is driven by technological advancements, rising prevalence of chronic diseases, and increasing R&D investments, spurred by an aging global population and the demand for improved patient-centric therapies. Biologics and biosimilars also bolster the need for advanced delivery systems. Key influencing growth factors include the integration of nanotechnology, polymer science advancements, and enhanced bioavailability applications. Opportunities for market players lie in exploring biodegradable polymers, remote drug delivery systems, and microencapsulation techniques. Developing better patient education tools and ensuring adherence can also open new avenues for market penetration.

However, challenges such as stringent regulatory requirements, high initial development costs, and complex drug release mechanisms pose significant barriers. Addressing biocompatibility issues and managing unexpected systemic release errors remain critical challenges. Stakeholders can capitalize on innovation by focusing on advanced material sciences, AI-driven personalized medicine solutions, and collaborations between biopharma companies and healthcare analytics firms. Additionally, developing environmentally sustainable practices can offer competitive advantages. A strategic emphasis on emerging markets in Asia-Pacific and Latin America, where healthcare access and infrastructure are improving rapidly, could also yield substantial returns. The nature of the market is competitive yet fragmented, with significant opportunities for both established players and startups that leverage technological advancements to meet growing healthcare demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Controlled Release Drug Delivery Market

The Controlled Release Drug Delivery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in Need for Controlled Release Dosage Forms for the Infants and Geriatric Population
    • Rising Adoption of Hydrogel and Osmotic Controlled Drug Delivery System
    • Need to Improve the Therapeutic Benefits, Reduce Drug Toxicity to Control Various Types of Illness
  • Market Restraints
    • Complex Manufacturing Process of Controlled Release Drug Delivery System
  • Market Opportunities
    • Potential Development of Nanotechnology in Advanced Medicine/Drug Formulations for Controlled-Release Drug Delivery System
    • Advances in Control Release Drug Delivery System
  • Market Challenges
    • Potential limitation of controlled drug release formulation

Porter's Five Forces: A Strategic Tool for Navigating the Controlled Release Drug Delivery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Controlled Release Drug Delivery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Controlled Release Drug Delivery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Controlled Release Drug Delivery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Controlled Release Drug Delivery Market

A detailed market share analysis in the Controlled Release Drug Delivery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Controlled Release Drug Delivery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Controlled Release Drug Delivery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Controlled Release Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Tandem Diabetes Care, Inc., Johnson & Johnson Services, Inc., Insulet Corporation, Merck & Co., Inc., Alkermes PLC, GlaxoSmithKline PLC, Becton, Dickinson and Company, Pensatech Pharma GmbH, Celares GmbH, Trelleborg AB, Lonza Group Ltd., Celanese Corporation, Boehringer Ingelheim International GmbH, CURE Pharmaceutical, Baxter International Inc., Medtronic PLC, Colorcon, Inc., Adare Pharma Solutions, Collegium Pharmaceutical, Inc., Pfizer Inc., Catalent, Inc., Avantor, Inc., Corium, Inc., AMW GmbH, Seqens, Biogen Inc., Coating Place, Inc., and AstraZeneca PLC.

Market Segmentation & Coverage

This research report categorizes the Controlled Release Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Release Mechanism, market is studied across Activation-Modulated Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, and Polymer Based Systems. The Activation-Modulated Drug Delivery Systems is further studied across Hydrodynamic Pressure Activated, Magnetically Activated, Mechanically Activated, Osmotic Pressure Activated, and Vapor Pressure Activated. The Chemically Activated is further studied across Enzyme Activated, Hydrolysis Activated, and pH Activated.
  • Based on Technology, market is studied across Coacervation, Implants, Micro Encapsulation, Targeted Delivery, Transdermal, and Wurster Technique.
  • Based on Application, market is studied across Drug Eluting Stents, Infusion Pumps, Injectable, Metered Dose Inhalers, Oral Controlled-Drug Delivery Systems, and Transdermal & Ocular Patches.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in Need for Controlled Release Dosage Forms for the Infants and Geriatric Population
      • 5.1.1.2. Rising Adoption of Hydrogel and Osmotic Controlled Drug Delivery System
      • 5.1.1.3. Need to Improve the Therapeutic Benefits, Reduce Drug Toxicity to Control Various Types of Illness
    • 5.1.2. Restraints
      • 5.1.2.1. Complex Manufacturing Process of Controlled Release Drug Delivery System
    • 5.1.3. Opportunities
      • 5.1.3.1. Potential Development of Nanotechnology in Advanced Medicine/Drug Formulations for Controlled-Release Drug Delivery System
      • 5.1.3.2. Advances in Control Release Drug Delivery System
    • 5.1.4. Challenges
      • 5.1.4.1. Potential limitation of controlled drug release formulation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Release Mechanism: Increasing R&D activities for development of robust chemically activated system
    • 5.2.2. Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects
    • 5.2.3. Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Controlled Release Drug Delivery Market, by Release Mechanism

  • 6.1. Introduction
  • 6.2. Activation-Modulated Drug Delivery Systems
    • 6.2.1. Hydrodynamic Pressure Activated
    • 6.2.2. Magnetically Activated
    • 6.2.3. Mechanically Activated
    • 6.2.4. Osmotic Pressure Activated
    • 6.2.5. Vapor Pressure Activated
  • 6.3. Chemically Activated
    • 6.3.1. Enzyme Activated
    • 6.3.2. Hydrolysis Activated
    • 6.3.3. pH Activated
  • 6.4. Feedback Regulated Drug Delivery Systems
  • 6.5. Micro Reservoir Partition Controlled Drug Delivery Systems
  • 6.6. Polymer Based Systems

7. Controlled Release Drug Delivery Market, by Technology

  • 7.1. Introduction
  • 7.2. Coacervation
  • 7.3. Implants
  • 7.4. Micro Encapsulation
  • 7.5. Targeted Delivery
  • 7.6. Transdermal
  • 7.7. Wurster Technique

8. Controlled Release Drug Delivery Market, by Application

  • 8.1. Introduction
  • 8.2. Drug Eluting Stents
  • 8.3. Infusion Pumps
  • 8.4. Injectable
  • 8.5. Metered Dose Inhalers
  • 8.6. Oral Controlled-Drug Delivery Systems
  • 8.7. Transdermal & Ocular Patches

9. Americas Controlled Release Drug Delivery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Controlled Release Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Controlled Release Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. DelSiTech Announces Closing of EUR 10 Million Financing Round to Advance its Silica-Based Drug Delivery Technology Platform
    • 12.3.2. Chiesi Global Rare Diseases and Aliada Therapeutics Partner to Advance Blood-Brain Barrier-Crossing Platform Technology for Drug Delivery

Companies Mentioned

  • 1. Tandem Diabetes Care, Inc.
  • 2. Johnson & Johnson Services, Inc.
  • 3. Insulet Corporation
  • 4. Merck & Co., Inc.
  • 5. Alkermes PLC
  • 6. GlaxoSmithKline PLC
  • 7. Becton, Dickinson and Company
  • 8. Pensatech Pharma GmbH
  • 9. Celares GmbH
  • 10. Trelleborg AB
  • 11. Lonza Group Ltd.
  • 12. Celanese Corporation
  • 13. Boehringer Ingelheim International GmbH
  • 14. CURE Pharmaceutical
  • 15. Baxter International Inc.
  • 16. Medtronic PLC
  • 17. Colorcon, Inc.
  • 18. Adare Pharma Solutions
  • 19. Collegium Pharmaceutical, Inc.
  • 20. Pfizer Inc.
  • 21. Catalent, Inc.
  • 22. Avantor, Inc.
  • 23. Corium, Inc.
  • 24. AMW GmbH
  • 25. Seqens
  • 26. Biogen Inc.
  • 27. Coating Place, Inc.
  • 28. AstraZeneca PLC

LIST OF FIGURES

  • FIGURE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTROLLED RELEASE DRUG DELIVERY MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 247. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023